CoChat

Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial

Open access
Blümcke, Ingmar, Coras, Roland, Busch, Robyn M., Morita‐Sherman, Marcia, Lal, Dennis, Prayson, Richard, Cendes, Fernando, Lopes‐Cendes, Iscia, Rogerio, Fabio, Almeida, Vanessa S., Rocha, Cristiane S., Sim, Nam Suk, Lee, Jeong Ho, Kim, Se Hoon, Baulac, Stephanie, Baldassari, Sara, Adle‐Biassette, Homa, Walsh, Christopher A., Bizzotto, Sara, Doan, Ryan N., Morillo, Katherine S., Aronica, Eleonora, Mühlebner, Angelika, Becker, Albert, Cienfuegos, Jesus, Garbelli, Rita, Giannini, Caterina, Honavar, Mrinalini, Jacques, Thomas S., Thom, Maria, Mahadevan, Anita, Miyata, Hajime, Niehusmann, Pitt, Sarnat, Harvey B., Söylemezoglu, Figen, Najm, Imad · 2021 · Epilepsia
Cited by 96

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective: Focal cortical dysplasia (FCD) is a major cause of difficult‐to‐treat epilepsy in children and young adults, and the diagnosis is currently based on microscopic review of surgical brain tissue using the International League Against Epilepsy classification scheme of 2011. We developed an iterative histopathological agreement trial with genetic testing to identify areas of diagnostic challenges in this widely used classification scheme. Methods: Four web‐based digital pathology trials were completed by 20 neuropathologists from 15 countries using a consecutive series of 196 surgical tissue blocks obtained from 22 epilepsy patients at a single center. Five independent genetic laboratories performed screening or validation sequencing of FCD‐relevant genes in paired brain and blood samples from the same 22 epilepsy patients. Results: Histopathology agreement based solely on hematoxylin and eosin stainings was low in Round 1, and gradually increased by adding a panel of immunostainings in Round 2 and the Delphi consensus method in Round 3. Interobserver agreement was good in Round 4 (kappa = .65), when the results of genetic tests were disclosed, namely, MTOR, AKT3, and SLC35A2 brain somatic mutations in five cases and germline mutations in DEPDC5 and NPRL3 in two cases. Significance: The diagnoses of FCD 1 and 3 subtypes remained most challenging and were often difficult to differentiate from a normal homotypic or heterotypic cortical architecture. Immunohistochemistry was helpful, however, to confirm the diagnosis of FCD or no lesion. We observed a genotype–phenotype association for brain somatic mutations in SLC35A2 in two cases with mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy. Our results suggest that the current FCD classification should recognize a panel of immunohistochemical stainings for a better histopathological workup and definition of FCD subtypes. We also propose adding the level of genetic findings to obtain a comprehensive, reliable, and integrative genotype–phenotype diagnosis in the near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/epi.16899

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Blümcke, I., Coras, R., Busch, R. M., Morita‐Sherman, M., Lal, D., Prayson, R., Cendes, F., Lopes‐Cendes, I., Rogerio, F., Almeida, V. S., Rocha, C. S., Sim, N. S., Lee, J. H., Kim, S. H., Baulac, S., Baldassari, S., Adle‐Biassette, H., Walsh, C. A., Bizzotto, S., Doan, R. N., Morillo, K. S., Aronica, E., Mühlebner, A., Becker, A., Cienfuegos, J., Garbelli, R., Giannini, C., Honavar, M., Jacques, T. S., Thom, M., Mahadevan, A., Miyata, H., Niehusmann, P., Sarnat, H. B., Söylemezoglu, F., & Najm, I.
Venue
Epilepsia
Publisher
Wiley
Published
2021-05-05
Volume
62
Issue
6
Pages
1416-1428
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W3157040976
Cited by
96
References
6
FWCI
11.58
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.